Trimipramine fails to exert antimanic efficacy: a case of the discrepancy between in vitro rationale and clinical efficacy.

Research output: Contribution to journal › Case report › peer-review

4 Citations (Web of Science)

Original language	English
Pages (from-to)	298-300
Journal	CLINICAL NEUROPHARMACOLOGY
Volume	22
Issue number	5
Publication status	Published - 1999

Cite this

Grunze, H., Erfurth, A., & Walden, J. (1999). Trimipramine fails to exert antimanic efficacy: a case of the discrepancy between in vitro rationale and clinical efficacy. CLINICAL NEUROPHARMACOLOGY , 22(5), 298-300.

@article{0549eaad57da4892ba0517f9a9d7e456,

title = "Trimipramine fails to exert antimanic efficacy: a case of the discrepancy between in vitro rationale and clinical efficacy.",

author = "Heinz Grunze and A Erfurth and J Walden",

year = "1999",

language = "English",

volume = "22",

pages = "298--300",

journal = "CLINICAL NEUROPHARMACOLOGY ",

issn = "0362-5664",

number = "5",

}

Grunze, H, Erfurth, A & Walden, J 1999, 'Trimipramine fails to exert antimanic efficacy: a case of the discrepancy between in vitro rationale and clinical efficacy.', CLINICAL NEUROPHARMACOLOGY , vol. 22, no. 5, pp. 298-300.

Trimipramine fails to exert antimanic efficacy: a case of the discrepancy between in vitro rationale and clinical efficacy. / Grunze, Heinz; Erfurth, A; Walden, J.
In: CLINICAL NEUROPHARMACOLOGY , Vol. 22, No. 5, 1999, p. 298-300.

Research output: Contribution to journal › Case report › peer-review

TY - JOUR

T1 - Trimipramine fails to exert antimanic efficacy: a case of the discrepancy between in vitro rationale and clinical efficacy.

AU - Grunze, Heinz

AU - Erfurth, A

AU - Walden, J

PY - 1999

Y1 - 1999

M3 - Case report

C2 - 10516883

SN - 0362-5664

VL - 22

SP - 298

EP - 300

JO - CLINICAL NEUROPHARMACOLOGY

JF - CLINICAL NEUROPHARMACOLOGY

IS - 5

ER -

Grunze H, Erfurth A, Walden J. Trimipramine fails to exert antimanic efficacy: a case of the discrepancy between in vitro rationale and clinical efficacy. CLINICAL NEUROPHARMACOLOGY . 1999;22(5):298-300.